Skip to main content

Sight Sciences, Inc.

SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001531177

In the last 90 days, Sight Sciences, Inc. insiders filed 0 open-market purchases and 6 sales; 112 institutions reported holding it in 13F filings for Q2 2026, worth $118.5M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Sight Sciences, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of SGHT: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders6866−2
Shares24.2M24.5M+312.9K (+1.3%)
Value$153.8M$299.5M+$145.7M (+94.7%)

New holders (15)

Institutions that held Sight Sciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to SGHT in Q4 2022
InstitutionSharesValue% of portfolio
Lord, Abbett & Co. LLC353,782$4.32M0.02%
Parkman Healthcare Partners LLC105,102$1.28M0.34%
Ameriprise Financial Inc64,886$792.0K0.00%
Schonfeld Strategic Advisors LLC29,500$360.2K0.00%
State of Wisconsin Investment Board25,200$307.7K0.00%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.21,649$266.7K0.00%
PDT Partners, LLC14,185$173.2K0.03%
Jane Street Group, LLC12,384$151.2K0.00%
MetLife Investment Management12,216$149.2K0.00%
Alliancebernstein L.P.12,200$149.0K0.00%
Principal Financial Group Inc10,344$126.3K0.00%
Lazard Asset Management LLC4,499$54.0K0.00%
Huntington National Bank2,500$30.5K0.00%
Metropolitan Life Insurance Co1,597$19.5K0.00%
Capital Advisors, Ltd. LLC19$00.00%

Sold out (17)

Institutions that held Sight Sciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.